US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 134 actively recruiting studies with Louisiana sites out of 134 registered in total. The busiest research areas in Louisiana are Obesity, Systemic Lupus Erythematosus, Endometrial Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), Novartis Pharmaceuticals, Pennington Biomedical Research Center. By stage, Louisiana trials break down as Phase 1 (12), Phase 2 (27), Phase 3 (57), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
134
Recruiting Now
134
← Back to US Map
Top Conditions in Louisiana
Obesity (4)Systemic Lupus Erythematosus (3)Endometrial Cancer (3)Asthma (2)Prostate Cancer (2)Interstitial Lung Disease (2)Acute Myeloid Leukemia (2)Stroke (2)Prostatic Neoplasms, Castration-Resistant (2)Acne (2)Lung Non-Small Cell Carcinoma (2)Melanoma (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 134 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 134. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Obesity, Systemic Lupus Erythematosus, Endometrial Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT06574217 N/A
Recruiting
Evaluation of Stepping Stones
Condition
Teen Pregnancy Prevention
Enrollment
650 pts
Location
United States
Sponsor
The Policy & Research Group
View Trial →
NCT06257693 Phase 1
Recruiting
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Condition
Prostate Adenocarcinoma
Enrollment
56 pts
Location
United States
Sponsor
Alessa Therapeutics Inc.
View Trial →
NCT05235165 Phase 3
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients ...
Condition
Metastatic Malignant Neoplasm in the Lung
Enrollment
62 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT02981628 Phase 2
Recruiting
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma...
Condition
Recurrent B Acute Lymphoblastic Leukemia
Enrollment
80 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT05168163 Phase 2
Recruiting
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of U...
Condition
Locally Advanced Hepatocellular Carcinoma
Enrollment
122 pts
Location
United States
Sponsor
Academic and Community Cancer
View Trial →
NCT06806033 Phase 2
Recruiting
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile fo...
Condition
B-Cell Non-Hodgkins Lymphoma
Enrollment
100 pts
Location
United States, Australia, Canada
Sponsor
Hoffmann-La Roche
View Trial →
NCT05685433 N/A
Recruiting
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Eval...
Condition
Overactive Bladder
Enrollment
200 pts
Location
United States
Sponsor
Valencia Technologies Corporat
View Trial →
NCT07296484 Phase 2
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Condition
Type 2 Diabetes
Enrollment
1,500 pts
Location
United States
Sponsor
Sparrow Pharmaceuticals
View Trial →
NCT06792552 Phase 1
Recruiting
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
414 pts
Location
United States, China
Sponsor
NextCure, Inc.
View Trial →
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05039619 Phase 2
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab i...
Condition
Lupus Nephritis
Enrollment
40 pts
Location
United States, Brazil, Canada
Sponsor
Hoffmann-La Roche
View Trial →
NCT06855277 Phase 3
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With P...
Condition
Prostate Cancer
Enrollment
940 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06312137 Phase 3
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzum...
Condition
Non Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
View Trial →
NCT06492733 N/A
Recruiting
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Condition
Chronic Total Occlusion of Artery of the Extremities
Enrollment
65 pts
Location
United States
Sponsor
Versono Medical Ltd
View Trial →
NCT06472206 N/A
Recruiting
Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)
Condition
HIV/AIDS
Enrollment
420 pts
Location
United States
Sponsor
Columbia University
View Trial →
NCT06232304 N/A
Recruiting
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythemato...
Condition
Systemic Lupus Erythematosus of Childhood (Disorder)
Enrollment
175 pts
Location
United States, Canada
Sponsor
Michigan State University
View Trial →
NCT07195734 Phase 2
Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
180 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
View Trial →
NCT07213804 Phase 3
Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum...
Condition
Ovarian Neoplasms
Enrollment
1,630 pts
Location
United States, Australia, Austria
Sponsor
Eli Lilly and Company
View Trial →
NCT07662044 Phase 3
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone o...
Condition
Type 2 Diabetes Mellitus
Enrollment
800 pts
Location
United States, Argentina, China
Sponsor
AstraZeneca
View Trial →
NCT07221851 Phase 3
Recruiting
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared...
Condition
Turner Syndrome
Enrollment
186 pts
Location
United States, France, Germany
Sponsor
Ascendis Pharma A/S
View Trial →
NCT06249126 N/A
Recruiting
Primary Subtalar Arthrodesis for Calcaneal Fractures
Condition
Calcaneus Fracture
Enrollment
218 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT00196742 N/A
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Condition
Fabry Disease
Enrollment
9,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
View Trial →
Page 3 of 6 — 134 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology